Practice Variations in the Use of Novel Oral Anticoagulants for Nonvalvular Atrial Fibrillation-Related Stroke among Stroke Neurologists in Saudi Arabia

Clinical trials have demonstrated that novel oral anticoagulants (NOACs) are noninferior to warfarin in preventing nonvalvular atrial fibrillation- (nvAF-) related stroke and systemic embolism. However, in these trials, NOACs initiation was delayed for a variable period after stroke. Herein, we aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Alanazy, Mohammed H., Muayqil, Taim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721244/
https://www.ncbi.nlm.nih.gov/pubmed/31531241
http://dx.doi.org/10.1155/2019/5373250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721244/
https://www.ncbi.nlm.nih.gov/pubmed/31531241
http://dx.doi.org/10.1155/2019/5373250

Ejemplares similares